Art

J-GLOBAL ID：201902206779380650   Reference number：19S1676671

Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older

Author (29)： Meguro, Akiko (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Ozaki, Katsutoshi (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Sato, Kazuya (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Oh, Iekuni (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Fujiwara, Shinichiro (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Hosonuma, Rie (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Sasazaki, Miyuki (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Kikuchi, Yuji (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Hirata, Yuji (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Yamamoto, Chihiro (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Uesawa, Mitsuyo (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Kobayashi, Hiroyuki (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Matsu, Haruko (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Okabe, Hiroshi (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Uehara, Eisuke (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Nishikawa, Akinori (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Tatara, Raine (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Hatano, Kaoru (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Matsuyama, Tomohiro (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Ohmine, Ken (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Suzuki, Takahiro (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Mori, Masaki (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Mori, Masaki (Division of Cell Transplantation and Transfusion, Jichi Medical University) ,  Nagai, Tadashi (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Ozawa, Keiya (Division of Hematology, Department of Medicine, Jichi Medical University) ,  Yamamoto, Chizuru (Division of Cell Transplantation and Transfusion, Jichi Medical University) ,  Muroi, Kazuo (Division of Cell Transplantation and Transfusion, Jichi Medical University) ,  Toshima, Masaki (Department of Infection Prevention and Control, Jichi Medical University) ,  Ueda, Masuzu (Department of Clinical Oncology, Jichi Medical University)
Material： Leukemia and Lymphoma
Volume： 53  Issue： 1  Page： 43-49  Publication year： 2012 
JST Material Number： SCOPUS  ISSN： 1042-8194  CODEN： LELYE 
Country of issue： United Kingdom (GBR)  Language： English (EN)

Terms in the title (1)： rituximab